Simple obesity and application of TCM Piwei theory

doi:10.3969/j.issn.1674-490X.2022.03.009

Abstract

Abstract: Simple obesity refers to obesity without obvious disease inducement, which is caused by genetic factors and environmental factors.Clinical practice shows that the TCM treatment of simple obesity has the advantages of small side effects, significant curative effect and high degree of patient acceptance.The theory of Piwei plays an important role in the treatment of simple obesity as an important practical theoretical basis in the clinical application of TCM.This paper analyzes the etiology and pathogenesis of simple obesity by combining the clinical experience of the treatment of simple obesity in recent years, and systematically discusses the application of Piwei theory in the clinical treatment of simple obesity, so as to provide some reference for the guidance of clinical practice.

Key words: traditional Chinese medicine, simple obesity, pathogenesis, Piwei theory

CLC Number:

ZHANG Jinghui,ZHAO Hanqing,WANG Zewen,XIANG Hongwei,GE Shaoqin. Simple obesity and application of TCM Piwei theory[J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(3): 54-59.

References

[1] 杜立杰,杜丽坤,周海丽.中医药治疗单纯性肥胖的研究进展[J].中医药信息, 2020,37(2):129-131.DOI: 10.19656/j.cnki.1002-2406.200059.
[2] 张璐,杨跃进,温瑞,等.超重、肥胖和腹型肥胖与心血管代谢性疾病的关联研究[J].现代预防医学, 2016,43(21):3887-3891.
[3] 洪靖,翟煦,翟伟航,等.从微饮立论治疗单纯性肥胖早期病变思路[J].中华中医药杂志, 2021,36(12):7203-7206.
[4] 宋昌梅,杲春阳,付燕来,等.肥胖中医研究进展[J].现代中医药, 2021,41(3):6-9.DOI: 10. 13424/j.cnki.mtcm.2021.03.002.
[5] 田雪芳,王经武.论肥胖的膏、脂、肉分型与治疗[C].银川:第八届全国中西医结合营养学术会议, 2017:333-335.
[6] WANG H D, WANG C, HAN W X, et al. Association of leptin and leptin receptor polymorphisms with coronary artery disease in a North Chinese Han population.[J]. Rev soc Bras Med Trop, 2020,53:e20190388.DOI: 10.1590/0037-8682-0388-2019.
[7] 杨志宏,张小妮,王小娟,等.血清超敏C反应蛋白、chemerin、TG、及瘦素联合检测在2型糖尿病中的临床诊断价值研究[J].中国实验诊断学, 2019,23(5):833-837.DOI: 10.3969/j.issn.1007-4287.2019.05.020.
[8] 高铎,魏婧雅,孙鹏.营养因子对瘦素及其受体基因表达的影响[J].华北农学报, 2019,34(S1):394-403.
[9] IZOUIERDO A G, CRUJEIRAS A B, CASANUEVA F F, et al. Leptin, Obesity, and Leptin Resistance: Where Are We 25 Years Later?[J]. Nutrients, 2019,11(11):2704.DOI: 10.3390/nu11112704.
[10] 黄言瑾,陈金水.脂联素国内外研究进展[J].中西医结合心脑血管病杂志, 2014,12(2):234-236.DOI: 10.3969/j.iss.1672-1349.2014.02.054.
[11] 陈建,应汝炯,盛昭园.从炎症角度研究单纯性肥胖述评[J].河南中医, 2018,38(11):1773-1778.DOI: 10.16367/j.issn.1003-5028.2018.11.0472.
[12] 尹庚申,郭明明,余之刚.脂联素及其受体在肥胖相关的乳腺癌中的作用[J].中华乳腺病杂志(电子版), 2018,12(4):246-249.DOI: 10.3877/cma.j.issn.1674-0807.2018.04.011.
[13] 王光亚.脂联素与代谢性疾病的相关性及其改善胰岛素抵抗的机制研究[D].石家庄: 河北医科大学, 2021:80-84.
[14] 张红霞,赵娟,潘扬,等.中医药调节脂肪细胞因子表达和分泌的研究进展[J].时珍国医国药, 2013,24(11):2754-2756.
[15] 朱梦梦.化积健脾汤对单纯性肥胖小鼠糖脂代谢功能和瘦素抵抗的作用及机制研究[D].保定: 河河北大学, 2020:57-63.
[16] 周继刚,陈茂华,李小妹,等.红景天苷通过激活3T3-L1前脂肪细胞Nrf2/HO-1信号通路及下调脂肪生成转录因子表达来抑制脂肪生成[J].中药药理与临床, 2019,35(1):33-38.DOI: 10.13412/j.cnki.zyyl.2019.01.008.
[17] 赵雪梅,马俊花,陆建灿,等.姜黄素对代谢综合征模型大鼠脂肪细胞因子及p38 MAPK表达影响研究[J].辽宁中医药大学学报, 2019,21(7):33-37.DOI: 10.13194/j.issn.1673-842x.2019.07.009.
[18] 陆颖影,胡国勇,王兴鹏.肠道菌群与相关代谢性及消化系统疾病的关系[J].国际消化病杂志, 2015,35(2):126-128, 146. DOI: 10.3969/j.issn.1673-534X.2015.02.016.
[19] 何燕,陈栋,徐斌.中医药从脾论治肠道菌群与单纯性肥胖病[J]. 医学综述, 2019,25(21):4276-4280, 4285. DOI: 10.3969/j.issn.1006-2084.2019.21.022.
[20] ILYAS Z, PERNA S, AL-THAWADI S, et al. The effect of Berberine on weight loss in order to prevent obesity: a systematic review[J]. Biomed Pharmacother, 2020,127:110137. DOI: 10.1016/j.biopha.2020.110137.
[21] 何旭云,贺姣姣,郑宁宁,等.黄芪多糖对肥胖小鼠的减肥作用与调节肠道菌群的关系研究[J].世界中医药, 2016,11(11):2379-2384, 2388. DOI: 10.3969/j.issn.1673-7202.2016.11.046.
[22] 程玥,丁泽贤,张越,等.茯苓多糖及其衍生物的化学结构与药理作用研究进展[J].中国中药杂志, 2020, 45(18): 4332-4340. DOI: 10.19540/j.cnki.cjcmm.20200624.601.
[23] 高丽,张文慧,黄惠丽,等.苍术素现代研究概况[J].医学信息, 2018,31(17):37-40, 44. DOI: 10.3969/j.issn.1006-1959.2018.17.013.
[24] 王婵,杨颖博.荷叶的化学成分与药理活性研究进展[J]. 现代中药研究与实践, 2020,34(4):74-81.DOI: 10.13728/j.1673-6427.2020.04.017.
[25] 赵乐.泽泻降血脂研究概况[J].实用中医内科杂志, 2019,33(3):71-73, 77. DOI: 10.13729/j.issn.1671-7813.z20190089.
[26] 毕天琛,杨国宁,马海春.中药薏苡仁化学成分及药理活性研究进展[J].海峡药学, 2019,31(11):52-56.DOI: 10.3969/j.issn.1006-3765.2019.11.014.
[27] 张君,邵素菊,高希言.补脾泻胃针灸法治疗单纯性肥胖症的理论初探[J].中医学报, 2013,28(3):448-449.DOI: 10.16368/j.issn.1674-8999.2013.03.051.
[28] 范肃,张振宇,潘珺俊,等.针灸拔罐综合疗法治疗脾虚湿阻型单纯性肥胖的临床研究[J].中国中医基础医学杂志, 2020,26(1):88-90,93.
[29] 井庆彦.针刺配合拔罐治疗单纯性肥胖的临床效果观察[J].医学信息, 2018,31(16):139-141.DOI: 10.3969/j.issn.1006-1959.2018.16.044.
[30] 李海燕,徐芬,马朝阳.基于“标本配穴”理论针灸干预疗法对单纯性肥胖患者血脂水平及胰岛素抵抗的影响[J].中华中医药学刊, 2019,37(1):49-52.DOI: 10.13193/j.issn.1673-7717.2019.01.011.
[31] 黄琼.穴位埋线减肥对单纯性肥胖患者体重及血脂情况的影响[J].中医外治杂志, 2020,29(1):52-53.DOI: 10.3969/j.issn.1006-978X.2020.01.025.
[32] 段云庆,陈进,陈黎,等.穴位埋线治疗单纯性肥胖25例临床观察[J].云南中医中药杂志, 2018,39(2):66-67.DOI: 10.16254/j.cnki.53-1120/r.2018.02.032.
[33] 关晖勇,谭玉燕,关芬海. 肥胖症多学科管理和治疗方案的构建与实施效果[J].当代医学, 2021,27(26):4-7.DOI: 10.3969/j.issn.1009-4393.2021.26.002.